Heart transplantation (HTx) is a definitive treatment for selected patients with advanced heart failure. However, primary graft dysfunction (PGD), a severe early complication, is a major cause of post-HTx morbidity and mortality. This paper explores the pathophysiology, diagnostic approaches, and management strategies for PGD, with a particular focus on temporary mechanical circulatory support (MCS) devices such as venoarterial extracorporeal membrane oxygenation and Impella. It also highlights the essential role of the multidisciplinary Heart Team in optimizing outcomes through patient-tailored MCS selection and timely intervention.
Keywords: Advanced heart failure; Heart Team; Heart transplantation; Mechanical circulatory support; Multidisciplinary care; Primary graft dysfunction.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.